Day One Biopharmaceuticals, Inc. DAWN
21.53 USD 0.00 (+0.00%)
Apr 24, 2026, 9:30 AM EDT
21.53 Day range 21.53
52-week range unavailable
- YTD
- +131.01%
- 1 year
- +172.53%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 158.18M | 131.16M | 0 | 0 | 0 | |
| 140.97M | 125.88M | 0 | 0 | 0 | |
| -127.75M | -217.27M | -206.06M | -146.91M | -72.74M | |
| -107.32M | -95.50M | -188.92M | -142.18M | -170.64M | |
| -1.04 | -1.02 | -2.37 | -2.17 | -4.62 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 197.08M | 124.97M | 230.78M | 85.26M | 284.31M | |
| 507.83M | 582.79M | 376.05M | 349.06M | 289.82M | |
| 66.67M | 80.04M | 29.51M | 17.02M | 8.67M | |
| 2.79M | 2.60M | 408.00K | 813.00K | 220.00K | |
| 441.16M | 502.75M | 346.54M | 332.04M | 281.15M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -103.76M | -78.11M | -146.85M | -109.87M | -48.54M | |
| 174.65M | -230.99M | 128.38M | -255.07M | -8.00M | |
| 1.22M | 203.29M | 164.00M | 165.90M | 297.12M | |
| -288.00K | 105.83M | -224.00K | -26.00K | 0 | |
| 72.11M | -105.82M | 145.52M | -199.05M | 240.58M |